Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Apr;29(4):10.1111/nmo.12981.
doi: 10.1111/nmo.12981. Epub 2016 Oct 25.

Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing

H P Parkman  1 , E K Hallinan  2 , W L Hasler  3 , G Farrugia  4 , K L Koch  5 , L Nguyen  6 , W J Snape  7 , T L Abell  8 , R W McCallum  9 , I Sarosiek  9 , P J Pasricha  2 , J Clarke  2 , L Miriel  2 , J Tonascia  2 , F Hamilton  10 ; NIDDK Gastroparesis Clinical Research Consortium (GpCRC)
Affiliations
Observational Study

Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing

H P Parkman et al. Neurogastroenterol Motil. 2017 Apr.

Abstract

Background: Early satiety (ES) and postprandial fullness (PPF) are often present in gastroparesis, but the importance of these symptoms in gastroparesis has not been well-described. The aims were: (i) Characterize ES and PPF in patients with gastroparesis. (ii) Assess relationships of ES and PPF with etiology of gastroparesis, quality of life, body weight, gastric emptying, and water load testing.

Methods: Gastroparetic patients filled out questionnaires assessing symptoms (PAGI-SYM) and quality of life (PAGI-QOL, SF-36v2). Patients underwent gastric emptying scintigraphy and water load testing.

Key results: 198 patients with gastroparesis (134 IG, 64 DG) were evaluated. Early satiety was severe or very severe in 50% of patients. Postprandial fullness was severe or very severe in 60% of patients. Severity scores for ES and PPF were similar between idiopathic and diabetic gastroparesis. Increasing severity of ES and PPF were associated with other gastroparesis symptoms including nausea/vomiting, satiety/early fullness, bloating, and upper abdominal pain and GERD subscores. Increasing severity of ES and PPF were associated with increasing gastroparesis severity, decreased BMI, decreased quality of life from PAGI-QOL and SF-36 physical health. Increasing severity of ES and PPF were associated with increasing gastric retention of a solid meal and decreased volume during water load test.

Conclusions & inferences: Early satiety and PPF are commonly severe symptoms in both diabetic and idiopathic gastroparesis. Early satiety and PPF severity are associated with other gastroparesis symptom severities, body weight, quality of life, gastric emptying, and water load testing. Thus, ES and PPF are important symptoms characterizing gastroparesis. ClinicalTrials.gov number: NCT NCT01696747.

Keywords: diabetic gastroparesis; early satiety; gastric emptying; gastroparesis.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest exist.

References

    1. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592–622. - PubMed
    1. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–2404. - PubMed
    1. Nguyen LA, Snape WJ., Jr Clinical presentation and pathophysiology of gastroparesis. Gastroenterol Clin North Am. 2015;44:21–30. - PubMed
    1. Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD) Neurogastroenterol Motil. 2012;24:456–63. - PubMed
    1. Hui R. Gastroparesis: Clinical evaluation of drugs for treatment: Guidance for industry. Food and Drug Administration Center for Drug Evaluation and Research (CDER); Jul, 2015.

Publication types

Associated data